多药耐药性的调节：处于临界状态。 - Suppr

Suppr

超能文献

Modulation of multidrug resistance: at the threshold.

作者信息

Sikic B I

出版信息

J Clin Oncol. 1993 Sep;11(9):1629-35. doi: 10.1200/JCO.1993.11.9.1629.

DOI:10.1200/JCO.1993.11.9.1629

PMID:8355032

Abstract

摘要

相似文献

Modulation of multidrug resistance: at the threshold.多药耐药性的调节：处于临界状态。

J Clin Oncol. 1993 Sep;11(9):1629-35. doi: 10.1200/JCO.1993.11.9.1629.

The reversal of multidrug resistance in cancer (review).癌症中多药耐药性的逆转（综述）

Anticancer Res. 1993 Jul-Aug;13(4):959-61.

[Multidrug resistance].

Vopr Onkol. 1991;37(7-8):780-8.

Multidrug resistance.

Sci Rep Res Inst Tohoku Univ Med. 1990 Dec;37(1-4):27-50.

Modulation of vinblastine resistance in metastatic renal cell carcinoma with cyclosporine A or tamoxifen: a cancer and leukemia group B study.环孢素A或他莫昔芬对转移性肾细胞癌长春碱耐药性的调节作用：一项癌症与白血病B组研究

Clin Cancer Res. 1997 Nov;3(11):1977-84.

Cancer chemotherapy. Progress in understanding multidrug resistance.

Nature. 1986;324(6096):407-8. doi: 10.1038/324407a0.

The multidrug resistance phenotype in human cancer.

Important Adv Oncol. 1991:19-38.

[Drug resistance and a strategy to eradicate resistant malignant cells].

Gan To Kagaku Ryoho. 1989 Apr;16(4 Pt 2-1):1280-2.

Multidrug resistance.

Cancer Chemother Biol Response Modif. 1991;12:91-109.

Pediatric cancer forum examines chemotherapy variables.

J Natl Cancer Inst. 1991 Dec 4;83(23):1714-5. doi: 10.1093/jnci/83.23.1714.

引用本文的文献

Exploring research advances and future trends in drug resistance in multiple myeloma: A comprehensive bibliometric analysis.探索多发性骨髓瘤耐药性的研究进展与未来趋势：一项全面的文献计量分析。

Medicine (Baltimore). 2025 Sep 5;104(36):e44279. doi: 10.1097/MD.0000000000044279.

The challenge of drug resistance in cancer treatment: a current overview.癌症治疗中的药物耐药性挑战：当前概述。

Clin Exp Metastasis. 2018 Apr;35(4):309-318. doi: 10.1007/s10585-018-9903-0. Epub 2018 May 24.

Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH.载有多柔比星的聚合物胶束通过双靶向叶酸受体和早期内体pH值克服癌症的多药耐药性。

Small. 2008 Nov;4(11):2043-50. doi: 10.1002/smll.200701275.

Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells.人慢性髓性白血病K562细胞对STI571耐药性的逆转。

Cancer Sci. 2003 Jun;94(6):557-63. doi: 10.1111/j.1349-7006.2003.tb01482.x.

Tetramethylpiperidine-substituted phenazines inhibit the proliferation of intrinsically multidrug resistant carcinoma cell lines.四甲基哌啶取代的吩嗪可抑制具有内在多药耐药性的癌细胞系的增殖。

Invest New Drugs. 2001;19(3):211-7. doi: 10.1023/a:1010691714635.

Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.右维拉帕米与表柔比星治疗转移性乳腺癌无效患者的II期试验

Br J Cancer. 1998 Apr;77(7):1155-63. doi: 10.1038/bjc.1998.192.

Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.通过用PSC833口服处理小鼠，实现肠道P-糖蛋白的完全阻断以及血脑屏障P-糖蛋白的广泛抑制。

J Clin Invest. 1997 Nov 15;100(10):2430-6. doi: 10.1172/JCI119784.

Classical multidrug resistance in acute myeloid leukaemia.急性髓系白血病中的经典多药耐药性

Med Oncol. 1997 Mar;14(1):53-60. doi: 10.1007/BF02990947.

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins.缺乏mdr1型（药物转运）P-糖蛋白的小鼠的正常生存能力及改变的药代动力学

Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4028-33. doi: 10.1073/pnas.94.8.4028.

Molecular biology of leukemia for the clinician.

Med Oncol. 1995 Sep;12(3):157-66. doi: 10.1007/BF01571193.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验